Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-30 Purchase |
2024-11-01 4:15 pm |
enGene Holdings Inc. | ENGN | Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner |
561,797 | $8.9 | $4,999,993 | 6,798,362 (Indirect Direct) |
View |
| 2023-12-27 Purchase |
2024-10-18 4:15 pm |
enGene Holdings Inc. | ENGN | Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner |
470,633 | $6.4013 | $3,012,674 | 6,236,565 (Indirect Direct) |
View |
| 2024-09-27 Purchase |
2024-10-01 08:02 am |
enGene Holdings Inc. | ENGN | Cooper Ronald Harold Wilfred Chief Executive Officer |
10,000 | $5.7 | $57,000 | 10,000 (Direct) |
View |
| 2024-04-18 Sale |
2024-04-22 5:22 pm |
enGene Holdings Inc. | ENGN | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% Owner |
52,529 | $15 | $787,981 | 3,036,153 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-29 Option Award |
2025-01-31 4:46 pm |
N/A 2035-01-29 |
enGene Holdings Inc. | ENGN | Pruthi Raj Som Chief Medical Officer |
280,000 | $0 | 280,000 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 4:44 pm |
N/A 2035-01-29 |
enGene Holdings Inc. | ENGN | Nichols Alexander Julian Chief Strategy & Ops. Ofc |
250,000 | $0 | 250,000 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 4:42 pm |
N/A 2035-01-29 |
enGene Holdings Inc. | ENGN | Giguere Lee Chief Legal Ofc. and Corp Secy |
250,000 | $0 | 250,000 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 4:40 pm |
N/A 2035-01-29 |
enGene Holdings Inc. | ENGN | Daws D. Ryan Chief Financial Officer |
280,000 | $0 | 280,000 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 4:38 pm |
N/A 2035-01-29 |
enGene Holdings Inc. | ENGN | CHEUNG ANTHONY TZEYEW Chief Scientific Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 4:36 pm |
N/A 2035-01-29 |
enGene Holdings Inc. | ENGN | Cooper Ronald Harold Wilfred CEO & President |
850,000 | $0 | 850,000 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-22 4:08 pm |
N/A 2034-10-21 |
enGene Holdings Inc. | ENGN | CHEUNG ANTHONY TZEYEW Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-22 4:07 pm |
N/A 2034-10-21 |
enGene Holdings Inc. | ENGN | Connolly Joan Chief Technology Officer |
210,000 | $0 | 210,000 (Direct) |
View |
| 2024-07-24 Option Award |
2024-07-25 8:32 pm |
N/A 2034-07-24 |
enGene Holdings Inc. | ENGN | Pruthi Raj Som Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
Ownership |
2024-07-25 8:30 pm |
N/A 2034-04-22 |
enGene Holdings Inc. | ENGN | Pruthi Raj Som Chief Medical Officer |
0 | $0 | 125,000 (Direct) |
View |
| 2024-07-22 Option Award |
2024-07-24 6:26 pm |
N/A 2034-07-22 |
enGene Holdings Inc. | ENGN | Cooper Ronald Harold Wilfred Chief Executive Officer |
1,250,000 | $0 | 1,250,000 (Direct) |
View |
| 2024-06-15 Option Award |
2024-06-18 4:09 pm |
N/A 2034-06-15 |
enGene Holdings Inc. | ENGN | Zoth Lota S. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-06-15 Option Award |
2024-06-18 4:08 pm |
N/A 2034-06-15 |
enGene Holdings Inc. | ENGN | HASTINGS PAUL J Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-15 Option Award |
2024-06-18 4:08 pm |
N/A 2034-06-15 |
enGene Holdings Inc. | ENGN | Joustra Wouter Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-15 Option Award |
2024-06-18 4:06 pm |
N/A 2034-06-15 |
enGene Holdings Inc. | ENGN | Glickman Richard M Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-06-15 Option Award |
2024-06-18 4:05 pm |
N/A 2034-06-15 |
enGene Holdings Inc. | ENGN | Bos Jasper Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-06-15 Option Award |
2024-06-18 4:04 pm |
N/A 2034-06-15 |
enGene Holdings Inc. | ENGN | BRUNK GERALD A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-05-28 Exercise |
2024-05-29 6:12 pm |
N/A N/A |
enGene Holdings Inc. | ENGN | Glickman Richard M Director |
120 | $0.89 | 24,675 (Direct) |
View |
| 2024-05-28 Exercise |
2024-05-29 6:12 pm |
N/A N/A |
enGene Holdings Inc. | ENGN | Glickman Richard M Director |
120 | $0 | 24,675 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 4:01 pm |
N/A 2034-03-21 |
enGene Holdings Inc. | ENGN | Zoth Lota S. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-20 4:42 pm |
N/A N/A |
enGene Holdings Inc. | ENGN | CHEUNG ANTHONY TZEYEW Chief Technology Officer |
52,940 | $0.89 | 102,873 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-20 4:42 pm |
N/A N/A |
enGene Holdings Inc. | ENGN | CHEUNG ANTHONY TZEYEW Chief Technology Officer |
52,940 | $0 | 102,873 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-19 4:05 pm |
N/A 2034-03-15 |
enGene Holdings Inc. | ENGN | Giguere Lee Chief Legal Ofc. and Corp Secy |
225,000 | $0 | 225,000 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-21 4:20 pm |
N/A N/A |
enGene Holdings Inc. | ENGN | BRUNK GERALD A Director 10% Owner |
800,000 | $10 | 2,855,648 (Indirect) |
View |
| 2024-02-20 Option Award |
2024-02-21 4:20 pm |
N/A N/A |
enGene Holdings Inc. | ENGN | Lumira Capital Investment Management Inc. 10% Owner |
800,000 | $10 | 2,855,648 (Indirect) |
View |
| 2023-11-30 Option Award |
2023-12-04 5:55 pm |
N/A 2033-11-30 |
enGene Holdings Inc. | ENGN | BRYCE RICHARD PAUL Chief Medical Officer |
153,000 | $0 | 153,000 (Direct) |
View |
| 2023-11-30 Option Award |
2023-12-04 5:52 pm |
N/A 2033-11-30 |
enGene Holdings Inc. | ENGN | Daws D. Ryan Chief Financial Officer |
232,000 | $0 | 232,000 (Direct) |
View |
Ownership |
2023-11-13 4:48 pm |
N/A N/A |
enGene Holdings Inc. | ENGN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
0 | $0 | 3,154,418 (Direct) |
View |
Ownership |
2023-11-13 4:00 pm |
N/A N/A |
enGene Holdings Inc. | ENGN | Forbion Capital Fund III Cooperatief U.A. Forbion III Management B.V. 10% Owner |
0 | $0 | 3,369,811 (Direct) |
View |
Ownership |
2023-11-07 6:08 pm |
N/A N/A |
enGene Holdings Inc. | ENGN | Lumira Capital Investment Management Inc. 10% Owner |
0 | $0 | 3,381,853 (Indirect) |
View |
| 2023-10-31 Other |
2023-11-02 5:29 pm |
N/A N/A |
enGene Holdings Inc. | ENGN | Forbion Growth Sponsor FEAC I B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner |
3,397,223 | $0 | 11,347,693 (Indirect) |
View |